Developing The Next Generation Of Targeted Radionuclide Therapy For The Benefit Of Cancer Patients
Jenny Karlsson
Senior Director Targeted Radiopharmaceuticals
Bayer
12 August, 2026
Watch time: 20 Minutes
Highlights
Takeaways
PREMIUM CONTENT
Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.
Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.
Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.
Watch this next
No related market Insights




